AEMD Share Price Performance
US$0.69
-13.81 (-95.21%)
Price US$0.69
Share Pricen/a
No recently updated narratives available.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.